Marshall Wace
PAHC icon

Marshall Wace’s Phibro Animal Health PAHC Stock Holding History

Marshall Wace’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
10,833
+3,999
+59% +$169K ﹤0.01% 2667
2026
Q1 		$378K Buy
+6,834
New +$325K ﹤0.01% 2574
2023
Q4 		– Sell
-34,235
Closed -$437K – 2493
2023
Q3 		$437K Buy
+34,235
New +$485K ﹤0.01% 1761
2022
Q4 		– Sell
-28,569
Closed -$379K – 3298
2022
Q3 		$379K Sell
28,569
-8,128
-22% -$140K ﹤0.01% 2850
2022
Q2 		$702K Sell
36,697
-62,302
-63% -$1.18M ﹤0.01% 2636
2022
Q1 		$1.97M Buy
+98,999
New +$2M ﹤0.01% 2070
2021
Q4 		– Sell
-12,455
Closed -$268K – 4188
2021
Q3 		$268K Sell
12,455
-8,184
-40% -$197K ﹤0.01% 2696
2021
Q2 		$596K Sell
20,639
-25,053
-55% -$678K ﹤0.01% 2056
2021
Q1 		$1.11M Sell
45,692
-30,286
-40% -$684K 0.01% 1602
2020
Q4 		$1.48M Buy
75,978
+54,828
+259% +$1.01M 0.01% 1061
2020
Q3 		$369K Buy
+21,150
New +$451K ﹤0.01% 1313
2019
Q4 		– Sell
-40,893
Closed -$872K – 1973
2019
Q3 		$872K Sell
40,893
-54,199
-57% -$1.48M 0.01% 973
2019
Q2 		$3.02M Buy
95,092
+75,277
+380% +$2.36M 0.02% 650
2019
Q1 		$654K Sell
19,815
-13,407
-40% -$417K 0.01% 1059
2018
Q4 		$1.07M Buy
+33,222
New +$1.25M 0.01% 900
2016
Q3 		– Sell
-48,538
Closed -$906K – 1081
2016
Q2 		$906K Buy
+48,538
New +$1.01M 0.01% 730

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Marshall Wace's PAHC Position: Q2 2026 in Review

Marshall Wace increased its Phibro Animal Health (PAHC) stake by 59% in Q2 2026, buying an estimated $169K and bringing the position to 10,833 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

Marshall Wace first reported a position in PAHC in Q2 2016 and has held it in 16 quarters since. The position peaked at $3.02M in Q2 2019. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Marshall Wace held 10,833 shares of Phibro Animal Health worth $340K as of Q2 2026.
  • Marshall Wace bought 3,999 Phibro Animal Health shares in Q2 2026, an estimated $169K.
  • Phibro Animal Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2667 holding.
  • Marshall Wace first reported a position in Phibro Animal Health in Q2 2016 and has held it in 16 quarters since.
  • Marshall Wace's Phibro Animal Health position peaked at $3.02M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.